Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.
CONCLUSIONS: Rapid development of a live-attenuated RSV vaccine could contribute substantially to reducing the global burden of RSV disease.
PMID: 32871092 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - Category: Respiratory Medicine Authors: Karron RA, Atwell JE, McFarland EJ, Cunningham CK, Muresan P, Perlowski C, Libous J, Spector SA, Yogev R, Aziz M, Woods S, Wanionek K, Collins PL, Buchholz UJ Tags: Am J Respir Crit Care Med Source Type: research